Mrassf1a-Pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma

9Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Objectives: RASSF1A has been described to be differentially methylated between fetal and maternal DNA and can therefore be used as a universal sex-independent marker to confirm the presence of fetal sequences in maternal plasma. However, this requires highly sensitive methods. We have previously shown that Pyrophosphorolysis-activated Polymerization (PAP) is a highly sensitive technique that can be used in noninvasive prenatal diagnosis. In this study, we have used PAP in combination with bisulfite conversion to develop a new universal methylation-based assay for the detection of fetal methylated RASSF1A sequences in maternal plasma. Methods: Bisulfite sequencing was performed on maternal genomic (g)DNA and fetal gDNA from chorionic villi to determine differentially methylated regions in the RASSF1A gene using bisulfite specific PCR primers. Methylation specific primers for PAP were designed for the detection of fetal methylated RASSF1A sequences after bisulfite conversion and validated. Results: Serial dilutions of fetal gDNA in a background of maternal gDNA show a relative percentage of ∼3% can be detected using this assay. Furthermore, fetal methylated RASSF1A sequences were detected both retrospectively as well as prospectively in all maternal plasma samples tested (n = 71). No methylated RASSF1A specific bands were observed in corresponding maternal gDNA. Specificity was further determined by testing anonymized plasma from non-pregnant females (n = 24) and males (n = 21). Also, no methylated RASSF1A sequences were detected here, showing this assay is very specific for methylated fetal DNA. Combining all samples and controls, we obtain an overall sensitivity and specificity of 100% (95% CI 98.4%-100%). Conclusions: Our data demonstrate that using a combination of bisulfite conversion and PAP fetal methylated RASSF1A sequences can be detected with extreme sensitivity in a universal and sex-independent manner. Therefore, this assay could be of great value as an addition to current techniques used in noninvasive prenatal diagnostics. © 2013 van den Oever et al.

References Powered by Scopus

MethPrimer: Designing primers for methylation PCRs

2215Citations
N/AReaders
Get full text

Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis

1454Citations
N/AReaders
Get full text

Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma

393Citations
N/AReaders
Get full text

Cited by Powered by Scopus

DNA methylation as a future therapeutic and diagnostic target in rheumatoid arthritis

83Citations
N/AReaders
Get full text

Noninvasive prenatal diagnosis of Huntington disease: Detection of the paternally inherited expanded CAG repeat in maternal plasma

24Citations
N/AReaders
Get full text

Implementation of whole genome massively parallel sequencing for noninvasive prenatal testing in laboratories

18Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Van Den Oever, J. M. E., Balkassmi, S., Segboer, T., Verweij, E. J., Van Der Velden, P. A., Oepkes, D., … Boon, E. M. J. (2013). Mrassf1a-Pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma. PLoS ONE, 8(12). https://doi.org/10.1371/journal.pone.0084051

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

63%

Researcher 6

32%

Professor / Associate Prof. 1

5%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 10

43%

Medicine and Dentistry 9

39%

Biochemistry, Genetics and Molecular Bi... 3

13%

Nursing and Health Professions 1

4%

Save time finding and organizing research with Mendeley

Sign up for free